1-3 of 3
Elias Kiwan
Close
Sort by
Journal Articles

Ninety Percent Sustained Complete Response (CR) Rate Projected 4 Years after Onset of CR in Gene Expression Profiling (GEP)-Defined Low-Risk Multiple Myeloma (MM) Treated with Total Therapy 3 (TT3): Basis for GEP-Risk-Adapted TT4 and TT5

Bart Barlogie, MD, PhD, Elias J. Anaissie, MD, John D. Shaughnessy, Jr., PhD, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, Jeff Haessler, MD, Klaus A. Hollmig, MD, Yazan Alsayed, MD, Sarah Waheed, MD, Monica Graziutti, MD, Elias Kiwan, MD, John Crowley, PhD
Journal: Blood
Blood (2008) 112 (11): 162.
https://doi.org/10.1182/blood.V112.11.162.162
Published: 2008
Journal Articles

Immune Reconstruction Inflammatory Syndrome (IRIS) with Invasive Aspergillosis (IA) in Patients (pts) with Hematological Cancer (Hem-Ca): Clinical and Research Implications.

Marisa Miceli, Monica Grazziutti, Gail Woods, Somashekar Krishna, Elias Kiwan, Mazher Rahman, Bart Barlogie, Elias Anaissie, Nayyar Syed
Journal: Blood
Blood (2006) 108 (11): 5313.
https://doi.org/10.1182/blood.V108.11.5313.5313
Published: 2006
Journal Articles

Validation of Serum Aspergillus Galactomannan Index as a Surrogate Endpoint for Outcome of Invasive Aspergillosis: Clinical and Research Implications.

Gail Woods, Marisa Miceli, Monica Grazziutti, Somashekar Krishna, Nayyar Syed, Elias Kiwan, Mazhar Rahman, Bart Barlogie, Elias Anaissie
Journal: Blood
Blood (2006) 108 (11): 2861.
https://doi.org/10.1182/blood.V108.11.2861.2861
Published: 2006